Valuation and Peers

Valuation and Peers

At Rp2,210 JPFA trades on about 6.4x its record FY2025 earnings, 5.0x the trailing twelve months, and 5.8x forward consensus — cheap in absolute terms. But most of that cheapness is not JPFA's own: the entire Indonesian poultry complex has de-rated from 20–35x a few years ago to single digits, and JPFA sits mid-pack, at a persistent discount to sector leader CPIN. On mid-cycle rather than peak earnings, the discount shrinks to roughly 8.5x.

The price in numbers

Sources: share price and yield per market data, 3 August 2026; earnings per share Rp344 and net profit to owners Rp4.00tn from the FY2025 Annual Report [1]; market cap = Rp2,210 x 11.63bn shares.

JPFA's 11.63 billion shares at Rp2,210 give a market capitalisation of about Rp25.7tn against FY2025 net profit to owners of Rp4.00tn and earnings per share of Rp344 [2]. That is 6.4x reported FY2025 earnings. Because the first quarter of 2026 ran well ahead of the prior year, trailing-twelve-month earnings per share is nearer Rp442, which pulls the trailing multiple down to about 5.0x; consensus of Rp383 for FY2026 puts it at 5.8x forward. The shares are down roughly 17% from about Rp2,670 in early February and sit below their end-2025 level, so the multiple is falling on rising, not falling, earnings.

Against book value the picture is less dramatic. Total equity was Rp20.0tn at the end of 2025, of which Rp1.36tn belongs to non-controlling interests, leaving about Rp18.7tn attributable to JPFA's own shareholders [3]. At Rp25.7tn the shares trade at about 1.4x that equity — a fuller multiple than the P/E, because the P/E is being flattered by a return on equity (21.4% in FY2025) near the top of the cycle. Which of those two lenses is right depends on how durable the earnings are — the question the Segment Economics tab framed and this one prices.

A discount the whole sector wears

The instinct on a 6x P/E is to look for a company-specific reason the market is wrong. For JPFA, the more accurate starting point is that the market applies the low multiple to the whole Indonesian poultry sector. CPIN — the largest and best-capitalised of the group — offers the clearest record of the shift: it commanded 20–35x earnings through 2016–2023 and has since compressed to the low teens on 2025 earnings and roughly 7x trailing today.

Source: CPIN annual price-to-earnings ratios per market data (companiesmarketcap.com); trailing P/E of about 7x as of 3 August 2026 per market data.

The re-rating down has several plausible causes — the sector's cyclicality became undeniable after the 2022–2023 trough, the growth premium that once attached to a structural-consumption story faded, and Indonesian small-caps broadly de-rated. Whatever the mix, the effect is that a single-digit multiple is now the sector's resting state, not a JPFA anomaly. Within that band, the multiples line up by size and balance-sheet quality.

Sources: trailing P/E, price-to-book and dividend yield per market data, 3 August 2026 (StockAnalysis for IDX names; CPF ratios per market data). Market caps for IDX names in Rupiah trillion; CPF is Thailand-listed (THB) and shown for multiples only. JPFA P/B derived from shareholders' equity of Rp18.7tn [4].

The ladder is orderly. CPIN, the largest and least-levered, carries the highest multiple at about 7x trailing and 9x forward. JPFA sits below it at roughly 5x trailing. Malindo — the smallest and most volatile of the listed integrators — trades at about 3x. The regional cross-check, Thailand's Charoen Pokphand Foods, trades near 7x earnings and below book value at 0.8x. Nothing in this group is expensive; JPFA is neither the cheapest nor the dearest.

Why JPFA sits below the leader

The gap between JPFA at ~5x and CPIN at ~7x is not noise — it maps to real differences a buyer is entitled to discount for.

The first is the balance sheet. CPIN runs with modest leverage — roughly Rp2.7tn of net debt against Rp35.9tn of equity, a net-debt-to-equity ratio around 8% — and market forecasts have it moving to a net-cash position within a couple of years. JPFA carries about Rp8.3tn of net debt against Rp20.0tn of equity, and its US$350m Sustainability-Linked Bond fell due in March 2026, a maturity the Financials and Estimates tab showed pushed the current ratio to its weakest of the three years. The bond looks funded, but a levered cyclical is always worth less per unit of peak earnings than a near-unlevered one.

The second is mix and independence. CPIN's earnings lean more heavily on the stable, higher-return feed business; JPFA's profit swings more with the broiler and breeding layer, as the Segment Economics tab quantified. And JPFA sources a large share of its feed raw material through Annona Pte Ltd, an affiliate of its controlling group — a related-party channel the Ownership and the Parent tab found aligned but unbenchmarked. A minority buyer pays less for earnings that pass through a related party at a price they cannot independently verify.

The third is the control overhang. With the Santoso family holding 55.4% through a parent that was itself taken private and delisted in 2025, JPFA is now the only listed window into the group. That concentration cuts both ways — aligned incentives, but a standing question about minority treatment if the controller ever moved to consolidate. None of these three is fatal; together they explain why the market pays a leader's premium to CPIN and a discount to JPFA, and they are the levers a re-rating would have to move.

Which earnings you capitalise

The multiple a reader lands on depends on which year's earnings they treat as normal. JPFA's operating margin has ranged from 4.3% at the 2023 trough to 11.7% at the 2016 peak, averaging about 8.3% across the decade; FY2025's 10.2% sits in the upper part of that band [5]. Capitalise a mid-cycle 8% margin on FY2025 revenue and net profit to owners falls to roughly Rp3.0tn, or about Rp260 per share — and the multiple the reader is really paying rises accordingly.

Source: derived — Rp2,210 share price divided by earnings per share on each basis; reported EPS Rp80/Rp344 and revenue/margin from the FY2025 Annual Report [6]; mid-cycle EPS assumes an 8% operating margin on FY2025 revenue.

Left to right, the chart frames the valuation debate. If FY2023's trough is the true through-cycle earnings power, JPFA is expensive at nearly 28x. If the trailing figure — flattered by a hot first quarter — is durable, it is 5x. The mid-cycle estimate of about 8.5x is the most defensible anchor: it is what the stock costs on the decade's average margin rather than the trough or the peak. That is a reasonable, not a compelling, price for a controlled cyclical with a related-party input channel.

Consensus takes the more optimistic side. Thirteen analysts rate the stock Strong Buy with a mean target of Rp3,168, about 43% above the current price. At that target the shares would fetch roughly 8.3x FY2026 consensus and about 12x the mid-cycle earnings estimate — a level that requires both that earnings hold well above mid-cycle and that the sector multiple recovers some of the ground it lost. The target is a bet on the durable-earnings case the bulls make; it is not what today's price assumes.

Margin of safety

The downside is bounded more by the balance sheet and the dividend than by the multiple. On the mid-cycle earnings estimate the shares are about 8.5x — not a level that needs a re-rating to avoid loss, but not the deep discount the headline 5x suggests either. The 6.5% trailing dividend yield offers some support, but it is not a fixed coupon: JPFA's payout policy runs at roughly 35–55% of earnings and tracks the cycle, so in a trough year like 2023 (EPS Rp80) even a full payout would yield closer to 1.5% at today's price. The yield moves with the same margin that drives earnings.

The evidence points to a stock that is genuinely cheap on peak earnings and reasonably — not aggressively — priced on normalised earnings, carrying a discount that is mostly the sector's and partly its own for reasons a careful buyer would keep. The strongest fact against a bullish read is that FY2025's 10.2% margin sits near the top of the decade's range, so the base case should assume some mean reversion rather than extrapolate the record. The read would change if the mid-2026 half-year statement showed the feed and broiler margins holding into a second year — evidence that the supply-managed cycle has lifted mid-cycle earnings power structurally, which would make even 8x normalised earnings look low — or, on the other side, if the margin began reverting toward the 6–8% band while the sector multiple stayed compressed, which would leave today's price fair rather than cheap.